Search results
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 9 hours agoEarlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR to...
...Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China...
Benzinga· 2 hours agoCGCS will showcase exclusive new data in the several areas, including solid tumor...
Is Bluebird Bio Stock a Buy?
The Motley Fool via AOL· 53 minutes agoBluebird Bio worth the risk? The challenge of gene editing Bluebird Bio has three approved gene-editing therapies: Zynteglo, Skysona, and Lyfgenia. The...
Gene therapy relieves back pain, repairs damaged d | Newswise
Newswise· 9 hours agoCOLUMBUS, Ohio – Disc-related back pain may one day meet its therapeutic match: gene therapy delivered by naturally derived nanocarriers that, a new study shows, repairs damaged ...
Biden's tariffs don't loosen China's grip on one key mineral in the EV economy
Business Insider via Yahoo News· 3 hours agoPresident Joe Biden this week hiked tariffs on China's massive green-tech sector, which includes...
New research identifies a larger pool of genes involved in age-related blood cell mutations than...
Medical Xpress· 2 days agoScientists have discovered 17 additional genes that drive the abnormal overgrowth of mutated blood...
Research finds exercise has a significant impact on immune cells that support brain function
Medical Xpress· 1 day agoNew research published in Aging Cell provides insights into how exercise may help to prevent or slow...
Herpes cure with gene editing makes progress in laboratory studies
Medical Xpress· 3 days agoPublished May 13 in Nature Communications, Jerome and his Fred Hutch team published an encouraging...
CRISPR can treat common form of inherited blindness, early data hint
Live Science via Yahoo News· 24 hours agoSuch problems happen due to mutations in any of at least 20 genes. Some of the most common causes of...
SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting...
WROC Rochester· 4 days agoIn preclinical studies, SCG142 demonstrated superior CD8+ and CD4+ TCR T cell proliferation and...
